On this page:

Implementing a Framework for Maternity Services in Scotland: Overview Report of the Expert Group on Acute Maternity Services

« Previous | Contents | Next »

Listen

Implementing A Framework for Maternity Services in Scotland

Appendix 2 Risk Assessment

Exit and entry examples to levels of maternity care

Section V explained the rationale for the identified entry and exclusion criteria to the different levels of maternity care. The attached tables provide examples of morbidities and co-morbidities which would not be suitable for delivery in the specified units, but this requires local and regional agreement and the development of guidelines and explicit networks. This list is not
all-inclusive, and examples are given for clarity. The identification criteria may be for referral at any level of care, for advice regarding management, or transfer to a higher level of care, depending on local agreements. It must be stressed that any woman with significant morbidity is not suitable for delivery in Level Ia-d. It is crucial that appropriate referral pathways are used for any mother and baby who give cause for concern.

Level IIa exit criteria, especially for maternal reasons, will require consultant obstetrician involvement and care will depend on the available level of service, local facilities and emergency support. Level IIc units should be able to care for the majority of pregnancies.

Though the document has concentrated on exclusion criteria, the following table identifies the women who are suitable to Level Ia-d of maternity care.

Exit examples for Level Ia-d care

Age

Parity

Height

Weight

Primigravida of >16
Primigravida of <40
Multigravida of <40

Multigravida <5

Height > 150 cms

Booking or 36 week weight BMI of >20 or <32

Exit examples for Level Ia-d: maternal medical/surgical history

Significant Respiratory Disease

Significant Neurological Disease

Cardiac Disorders

Significant asthma i.e. requiring previous hospitalisation or parenteral steroid therapy
Cystic fibrosis
Congenital abnormality
Emphysema (COPD)

Neurological disorders, including ME, MS
Epilepsy
Spina bifida/hydrocephaly
Paraplegia

Essential hypertension
Acquired heart disease - ischaemic heart disease, cardiomyopathy
Congenital heart disease - corrected or uncorrected

Haematological Disorders

Endocrine Disorders

Significant Gastro-intestinal Disorders

Haematological disease - e.g. thrombocytopenia, aplastic anaemia
Coagulation abnormality -
thrombophilia, disseminated
intravascular coagulation (DIC),
DVT, pulmonary embolus (any history)
Rhesus iso-immunisation including KELL
Haemoglobinopathies

Any endocrine disease
Diabetes (Type I and II) or gestational diabetes
Thyroid disease - (hypo and hyper)
Adrenal disease e.g. Addisons

Cholelithiasis
Fatty liver of pregnancy
Hepatobilary disease
Crohn's disease
Ulcerative colitis

Reproductive/Genital Tract

Musculo-Skeletal Disorders

Renal disease

Malformations of reproductive/
genital tract
Uterine surgery
Significant pelvic or cervical surgery

Trauma to pelvis, CDH, Kyphosis
Significant connective tissue disorder

Renal failure, impairment or dialysis

Infection

Malignant Disease

Significant Mental Illness

Significant infection e.g. Group B haemolytic streptococci
Any blood borne virus (HIV, Hep B,
Hep C)
Sepsis

Previous malignancy

Diagnosed schizophrenia
Manic depressive psychosis
Postnatal depression

Drug or Alcohol Intake

Surgery & Anaesthesia

Transplant Surgery

History of drug or alcohol abuse
There should be a review if the woman uses therapeutic medication

Any history of significant surgery or anaesthetic complication must be considered

Heart
Lung
Liver
Kidney

Genetic Disorders

Special Needs in Pregnancy

Marfan's syndrome
Ehlers Danlos syndrome

Will need to be independently considered, e.g.
Learning disability
Social exclusion
Refugee mother

Exit examples Level Ia-d: past obstetric and neonatal history

Antenatal

Fetal/Baby

Past delivery details

neonatal

Antepartum Haemorrhage (including recurrent placental abruption)

IUGR baby (<10th centile for gestational age)

Proven or suspected CPD

Stillbirth or neonatal death - case review required

Preterm labour (<37 weeks gestation)

Large Baby (> than 90th centile for gestational age)

Caesarean section

Previous neonatal birth injury

Pregnancy induced hypertension, eclampsia

Shoulder dystocia

Previous assisted mid cavity instrumental delivery

Previous baby with haemorrhagic disease of the newborn

Specific infections, e.g. HIV, Hepatitis carrier, Hep B, Hep C, Group B streptococcal

Postpartum haemorrhage (>500 mls primary or secondary)

Risk of, or known, inherited disease

Retained placenta

Previous iso-immunisation or ABO incompatibility

Perineal tear involving the anal sphincter (3rd or 4th degree tear)

Pelvic floor repair or cervical surgery

Exit examples Level Ia-d: present pregnancy

Maternal

Fetal

Combined

Maternal choice

Post-maturity >40/52+10 days

Multiple pregnancy

Hyperemesis gravidarum

Suspected or proven fetal abnormality

Preterm labour <37 completed weeks

Suspected PIH, raised BP

Intrauterine death

Membrane rupture <37 completed weeks

Cholestasis (including fatty liver of pregnancy and HELPP)

Malpresentation >37 completed weeks (including breech)

Raised AFP with abnormal growth scan at 34-36 weeks

IUGR by U/S (below 10th centile)

Anaemia (Hb <10 g/dl at 34-36 weeks)

Large for dates by U/S (over 90th centile)

Significant antepartum haemorrhage

ABO, rhesus iso -immunisation

Placental abruption

Current substance or alcohol misuse

Placenta praevia

Current therapeutic drug use (Benzodiazepines, any psychotropic drugs)

New medical disease not previously identified

Term rupture of membranes >12 hours

Maternal wish for epidural analgesia

Oligohydramnios

Maternal wish for Caesarean section or induction

Polyhydramnios

Newly identified malignancy

Maternal infection (HIV, Hepatitis carrier, Hep B, Hep C, Group B streptococcal)

Active viral infections such as chickenpox, rubella, measles, parvo-virus

Exit examples Level Ia-d: intrapartum

Maternal

Neonatal

Unstable lie

Maternal pyrexia >38ºC on two occasions (30 mins apart)

Retained placenta

Infants of <36 weeks gestation

Requirement for epidural analgesia

Intrapartum haemorrhage

Congenital malformation

Established labour >12 hours review evidence from partogram and guidelines (NICE/RCOG)

Meconium stained liquor Hypertension: diastolic of >100 mm/Hg on 2 occasions or a rise of 20/ suspicion of developing pre-eclampsia

Respiratory difficulties after resuscitation (respiratory rate >60/ min or requiring supplementary oxygen to maintain saturation >92%)

Prolonged rupture of membranes >12 hours

Prolonged active second stage

Birth weight <2200g

Abnormal fetal auscultation - fetal distress

3rd or 4th degree perineal tear

Apgar score 6 or less at 5 minutes of age

Malpresentation

Postpartum haemorrhage (>500 mls)

Infant gives cause for concern

Exit examples Level Ia-d: postnatal

Maternal

Neonatal

Postpartum haemorrhage

Neonatal seizures

Feeding difficulties persisting at 36 hours of age

Persisting hypoglycaemia

Sepsis

Persisting hypothermia

Failure to pass urine in first 24 hours

Failure to pass meconium in first 36 hours

Mother gives cause for concern

Jaundice in first 24 hours or positive Coombe's test

Exit examples Level IIa: past history

Significant Respiratory Disease

Significant Neurological Disease

Cardiac Disorders

Significant asthma i.e. requiring previous hospitalisation or parenteral steroid therapy
Cystic fibrosis
Congenital abnormality
Emphysema (COPD)
Certain congenital abnormalities

Neurological disorders, including ME, MS
Epilepsy
Spina bifida /hydrocephaly
Paraplegia

Congenital heart disease - corrected or uncorrected
Acquired heart disease - ischaemic heart disease, cardiomyopathy

Haematological Disorders

Endocrine Disorders

Significant Gastro-intestinal Disorders

Haematological disease - e.g. thrombocytopenia, aplastic anaemia
Coagulation abnormality -
thrombophilia, disseminated
intravascular coagulation
(DIC) DVT or pulmonary embolus (any history)

Significant endocrine disease
Significant medical disease especially if unstable (thyroid, adrenal disease e.g. Addisons)
Diabetes (Type I)

Fatty liver of pregnancy
Hepatobilary disease
Crohn's disease
Ulcerative colitis

Reproductive/Genital Tract

Musculo-Skeletal Disorders

Renal Disease

Cancer

Significant connective tissue disorder

Renal disease
Renal failure, impairment dialysis

Infection

Transplant Surgery

Significant Mental Illness

Significant infection e.g. Group B haemolytic streptococci
Any blood borne virus (HIV, Hep B, Hep C) Sepsis

Heart
Lung
Liver
Kidney

Diagnosed schizophrenia
Manic depressive psychosis

Drug or Alcohol Intake

Surgery & Anaesthesia

Genetic Disorders

History of drug or alcohol abuse
There should be a review if the woman uses therapeutic medication

Any history of significant surgery or anaesthetic complication must be considered

Marfan's syndrome
Ehlers Danlos syndrome

Special Needs in Pregnancy

Neonatal History

Will need to be independently considered e.g.
Learning disability
Social exclusion
Refugee mother

Any history of intrapartum asphyxia should be reviewed
Previous neonatal birth injury
Previous baby with haemorrhagic disease of the newborn
Risk of, or known, inherited disease
Previous iso-immunisation or ABO incompatibility

It is not advisable for any 'at risk' fetus to be delivered in a level IIa unit

Exit examples Level IIa: present pregnancy

Maternal

Fetal/Combined

Maternal choice

Maternal infection (HIV,

Hepatitis carrier, Hep B, Hep C, Group B streptococcal)

Post-maturity >40/52+10 days

New medical disease not previously identified

Polyhydramnios

Suspected or proven fetal abnormality

Significant antepartum haemorrhage

Oligohydramnios

Intrauterine death

Cholestasis (including fatty liver of pregnancy and HELPP)

Multiple pregnancy

Severe pregnancy induced hypertension

Preterm labour <37 completed weeks

Women at high obstetric anaesthetic risk

Membrane rupture <37 completed weeks

Women at high risk of obstetric interventions which may require assistance of interventional radiology (e.g. placenta accreta) or severe PPH >4000 mls

Malpresentation >37 completed weeks (including breech)

Raised AFP with abnormal growth scan at 34-36 weeks

Active viral infections such

as chickenpox, rubella,

measles, parvo-virus

Placental abruption

Current therapeutic drug use (Benzodiazepines, any psychotrophic drugs)

Placenta praevia

Large for dates by U/S (over 90th centile )

Newly diagnosed cancer

ABO, rhesus iso-immunisation

'At risk' fetus

Exit examples Level IIa: intrapartum

Maternal

Maternal/Combined

Fetus/Baby

Postpartum haemorrhage (>500 mls)

Intrapartum haemorrhage

Birth weight <2200g

3rd or 4th degree perineal tear

Large Baby >4000g

Mother gives cause for concern

Maternal pyrexia >38ºC on two occasions (30 mins apart)

Apgar score 6 or less at 5 minutes of age

Retained placenta

Newly diagnosed medical disease or morbidity

Respiratory difficulties after resuscitation (respiratory rate >60/min or requiring supplementary oxygen to maintain saturation >92%)

Placenta acreta

Infant gives cause for concern

Exit examples Level IIa: postnatal

Maternal

Neonatal

Postpartum haemorrhage

Neonatal seizures

Feeding difficulties persisting at 36 hours of age

Persisting hypoglycaemia

Sepsis

Persisting hypothermia

Failure to pass urine in first 24 hours

Failure to pass meconium in first 36 hours

Mother gives cause for concern

Baby gives cause for concern

Jaundice in first 24 hours/ positive Coombes test

Exit examples Level IIb: past history

Significant Respiratory Disease

Significant Neurological Disease

Cardiac Disorders

Emphysema (COPD)
Cystic fibrosis
Congenital abnormality

Spina bifida /hydrocephaly
Paraplegia

Congenital heart disease - corrected or uncorrected
Acquired heart disease - ischaemic heart disease, cardiomyopathy

Haematological Disorders

Endocrine Disorders

Transplant Surgery

Haematological disease - e.g. thrombocytopenia, aplastic anaemia
Coagulation abnormality -
thrombophilia, disseminated
intravascular coagulation (DIC)

Significant medical disease especially if unstable (thyroid , adrenal disease e.g. Addisons)
Diabetes (Type I)

Heart
Lung
Liver
Kidney

Reproductive/Genital Tract

Musculo-Skeletal Disorder

Renal disease

Cancer

Significant connective tissue disorder

Renal failure, impairment or dialysis

Infection

Genetic Disorders

Significant Mental Illness

Significant infection e.g. Group B haemolytic streptococci

Marfan's syndrome
Ehlers Danlos syndrome

Manic depressive psychosis

Fetus/Neonate

Any history of low birthweight babies should be reviewed

Exit examples for Level IIb: present pregnancy

Maternal

Fetal

Combined

Maternal choice

Below 10th centile for gestational age

Malpresentation <32 completed weeks

Malignancy identified in early pregnancy or any significant newly diagnosed morbidity

Suspected or proven fetal abnormality including cardiac, metabolic disorders, CNS or facial abnormality

Preterm labour <32 completed weeks

Women at high obstetric anaesthetic risk

Ultrasound identified twin-twin transfusion

Membrane rupture <32 completed weeks

Women at high risk of obstetric interventions which may require assistance of interventional radiology (e.g. placenta accreta) or severe PPH >4000 mls

Congenital diaphragmatic hernia

Severe pregnancy induced

hypertension (early onset,

<28 weeks gestation)

Abdominal wall defect

Severe IUGR (<1000g with delivery likely)

Urogenital malformations (genital malformations, posterior urethral valves)

High multiple pregnancies

Viral infection

Exit examples for Level IIc: past history

Significant Respiratory Disease

Significant Neurological Disease

Cardiac Disorders

Significant infection

Spina bifida /hydrocephaly
Paraplegia

Congenital heart disease - corrected or uncorrected
Acquired heart disease - ischaemic heart disease, cardiomyopathy

Haematological Disorders

Endocrine Disorders

Transplant Surgery

Haematological disease - e.g. thrombocytopenia, aplastic anaemia
Coagulation abnormality -
thrombophilia, disseminated
intravascular coagulation (DIC)

Significant medical disease if associated with severe complications

Heart
Lung
Liver
Kidney

Kidney Genetic Disorders

Musculo-Skeletal Disorders

Renal disease

Marfan's syndrome
Ehlers Danlos syndrome

Significant connective tissue disorder

Renal failure, impairment or dialysis

Exit examples for Level IIc: present pregnancy

Maternal

Fetal

Combined

Women at high obstetric anaesthetic risk

Suspected or proven fetal abnormality including cardiac, metabolic disorders, CNS or facial abnormality

Severe pregnancy induced hypertension (early onset, <28 weeks gestation)

Women at high risk of obstetric interventions which may require assistance of interventional radiology (e.g. placenta accreta) or severe PPH >4000 mls

Congenital diaphragmatic hernia

Severe IUGR (<1000g with delivery likely)

Malignancy identified in early pregnancy

Abdominal wall defect

High multiple pregnancies (depending on SCBU facilities)

Ultrasound identified twin-twin transfusion

Viral infection

Urogenital malformations (genital malformations, posterior urethral valves)

Entry examples for Level III

Maternal

Fetal

Neonate

Renal failure, impairment or dialysis

Suspected or proven fetal abnormality including, cardiac, metabolic disorders, CNS or facial abnormality

Need for assisted ventilation beyond initial resuscitation

Transplant surgery:
Heart
Lung
Liver
Kidney

Congenital diaphragmatic hernia

Persistent central cyanosis

Genetic disorders:
Marfan's syndrome
Ehlers Danlos syndrome

Abdominal wall defect

Congenital abnormality needing urgent surgical intervention

Ultrasound identified twin-twin
transfusion

Necrotising enterocolitis
(discretion of the consultant paediatrician)

Viral infection

Neonate less than 28 weeks gestation

Skeletal malformations

Need for specialist investigation and treatment e.g. metabolic problem which may require extraordinary therapies such as dialysis

Urogenital malformations (genital malformations, posterior uretheral valves)

« Previous | Contents | Next »

Page updated: Friday, June 24, 2005